| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 8 | |
| #2 | EPO (European Patent Office) | 6 | |
| #3 | WIPO (World Intellectual Property Organization) | 2 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Pharmaceuticals | |
| #3 | Measurement | |
| #4 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Microorganisms | |
| #2 | Medical preparations | |
| #3 | Analysing materials | |
| #4 | Therapeutic chemical compounds | |
| #5 | Animal care | |
| #6 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chien Kenneth R | 15 |
| #2 | Clarke Jonathan | 13 |
| #3 | Leung Chuen Yan | 10 |
| #4 | Foo Kylie | 4 |
| #5 | Lian Xiaojun | 4 |
| #6 | Lehtinen Miia | 4 |
| #7 | Chien Kenneth | 3 |
| #8 | Leung Chuen | 3 |
| #9 | Xu Jiejia | 3 |
| #10 | Sahara Makoto | 3 |
| Publication | Filing date | Title |
|---|---|---|
| EP3487988A1 | Use of neuropilin-1 (nrp1) as a cell surface marker for isolating human cardiac ventricular progenitor cells | |
| US2018148691A1 | Methods for isolating human cardiac ventricular progenitor cells | |
| US2017240964A1 | Genetic markers for engraftment of human cardiac ventricular progenitor cells | |
| US2016108363A1 | Use of LIFR or FGFR3 as a cell surface marker for isolating human cardiac ventricular progenitor cells | |
| EP3183337A1 | Use of jagged 1/frizzled 4 as a cell surface marker for isolating human cardiac ventricular progenitor cells |